BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1759 related articles for article (PubMed ID: 31926587)

  • 41. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Shen Q; Yu M; Jia JK; Li WX; Tian YW; Xue HZ
    Med Sci Monit; 2018 Apr; 24():2368-2376. PubMed ID: 29671412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
    Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
    Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SOX9 and IL1A as the Potential Gene Biomarkers of the Oral Cancer.
    Li T; Cheng D; Guo J; Chen H; Zhang S; Bao Y
    Comb Chem High Throughput Screen; 2023; 26(8):1461-1479. PubMed ID: 35762542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis.
    Jin D; Jiao Y; Ji J; Jiang W; Ni W; Wu Y; Ni R; Lu C; Qu L; Ni H; Liu J; Xu W; Xiao M
    PeerJ; 2020; 8():e9301. PubMed ID: 32587798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction of a circRNA-miRNA-mRNA network to explore the pathogenesis and treatment of pancreatic ductal adenocarcinoma.
    Xiao Y
    J Cell Biochem; 2020 Jan; 121(1):394-406. PubMed ID: 31232492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
    Xie R; Li B; Jia L; Li Y
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.
    Luan H; He Y; Zhang T; Su Y; Zhou L
    BMC Cancer; 2022 Apr; 22(1):463. PubMed ID: 35477379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules.
    Yang L; Jing J; Sun L; Yue Y
    Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.